Search - tctmd.com

Displaying 341 - 360 of 1179

Sort: Relevancy | Date

Presentation TCT 2019

Annular Reduction and 3D ICE

Presenter: Charles Davidson

September 26, 2019

Presentation TCT 2019

Onyx One: Results and Implications

Presenter: Azeem Latib

September 26, 2019

Presentation TCT 2019

Too Many Indices! How to Keep It Simple

Presenter: Jung-Min Ahn

September 26, 2019

Presentation TCT 2019

The Surgeon’s Perspective of TR Treatment: Advantages of Transcatheter Therapy

Presenter: Robert Smith

September 26, 2019

Presentation TCT 2019

Why Onyx One?

Presenter: Ajay Kirtane

September 26, 2019

Presentation TCT 2019

Coronary Physiology Has Evolved: Where Is It Going?

Presenter: Ziad Ali

September 26, 2019

Presentation TCT 2019

What Do We Really Know About Transcatheter Tricuspid Intervention?

Presenter: Francesco Maisano

September 26, 2019

Presentation TCT 2019

Who is the High Bleeding Risk Patient?

Presenter: Daniel Simon

September 26, 2019

Presentation TCT 2019

Welcome

Presenter: Morton Kern

September 26, 2019

Presentation TCT 2019

Using Mega-Data to Understand Tricuspid Valve Disease

Presenter: Maurice Sarano

September 26, 2019

Presentation TCT 2019

IDEAL-LM: A Randomized Trial of a Bioabsorbable Polymer DES With 4-Month DAPT vs. a Durable Polymer DES With 12-Month DAPT in Patients With Left Main Coronary Artery Disease

Presenter: Robert-Jan Van Geuns

September 26, 2019

Presentation TCT 2019

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor-Plus-Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

Presenter: Roxana Mehran

September 26, 2019

Presentation TCT 2019

Driving Quality in PCI: The Benefits of Complete Revascularization for Improvements in Ejection Fraction and Patient Quality of Life

Presenter: Ehtisham Mahmud

September 26, 2019

Presentation TCT 2019

SSO2 Therapy: Case Study

Presenter: Richard Schatz

September 26, 2019

Presentation TCT 2019

End-Stage AL Amyloidosis: Bridging With Counterpulsation Therapy in the Modern Heart Transplantation Era

Presenter: Kartik Telukuntla

September 26, 2019

Presentation TCT 2019

Emerging Drug-Free Platforms for the SFA: Can We Do Better Off Drugs?

Presenter: William Gray

September 26, 2019

Presentation TCT 2019

New Users' Perspective: Getting Started With the Carillon Mitral Contour System

Presenter: Matthias Lutz

September 26, 2019

Presentation TCT 2019

SSO2 Therapy: Clinical Evidence and Outcomes

Presenter: Gregg Stone

September 26, 2019

Presentation TCT 2019

FFR-guided Optimization Directed by HD IVUS: Insights into the Randomized FFR-REACT Trial

Presenter: Joost Daemen

September 26, 2019

Advertisement

Annular Reduction and 3D ICE

Onyx One: Results and Implications

Too Many Indices! How to Keep It Simple

The Surgeon’s Perspective of TR Treatment: Advantages of Transcatheter Therapy

Why Onyx One?

Coronary Physiology Has Evolved: Where Is It Going?

What Do We Really Know About Transcatheter Tricuspid Intervention?

Who is the High Bleeding Risk Patient?

Welcome

Using Mega-Data to Understand Tricuspid Valve Disease

IDEAL-LM: A Randomized Trial of a Bioabsorbable Polymer DES With 4-Month DAPT vs. a Durable Polymer DES With 12-Month DAPT in Patients With Left Main Coronary Artery Disease

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor-Plus-Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

Driving Quality in PCI: The Benefits of Complete Revascularization for Improvements in Ejection Fraction and Patient Quality of Life

SSO2 Therapy: Case Study

End-Stage AL Amyloidosis: Bridging With Counterpulsation Therapy in the Modern Heart Transplantation Era

Emerging Drug-Free Platforms for the SFA: Can We Do Better Off Drugs?

New Users' Perspective: Getting Started With the Carillon Mitral Contour System

SSO2 Therapy: Clinical Evidence and Outcomes

FFR-guided Optimization Directed by HD IVUS: Insights into the Randomized FFR-REACT Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content